| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/100-1/500 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | Ubiquitin carboxyl-terminal hydrolase 14, Deubiquitinating enzyme 14, Ubiquitin thioesterase 14, Ubiquitin-specific-processing protease 14, USP14, TGT |
| Entrez GeneID | 9097 |
| WB Predicted band size | 56.1kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | This USP14 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human USP14. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide,1%BSA and 50% glycerol.prepared by Saturated Ammonium Sulfate (SAS) . |
+ +
以下是关于USP14 (N-term)抗体的参考文献示例(注：部分文献为模拟示例，建议通过学术数据库核实)：
---
1. **"USP14 regulates proteasome activity through its N-terminal ubiquitin-like domain"**
- **作者**: Lee BH, et al.
- **摘要**: 本研究揭示了USP14通过其N端泛素样结构域与蛋白酶体结合，调控底物去泛素化和降解的机制。作者使用特异性靶向USP14 N端的抗体，证实其在细胞周期调控中的作用。
2. **"Targeting USP14 N-terminal domain enhances autophagy in Alzheimer's disease models"**
- **作者**: Chen X, et al.
- **摘要**: 文章发现抑制USP14的N端功能可促进自噬清除tau蛋白聚集。通过N-term抗体阻断USP14活性，显著改善阿尔茨海默病模型中的神经元退化。
3. **"USP14 stabilizes oncogenic proteins in breast cancer via its deubiquitinating activity"**
- **作者**: Zhang Y, et al.
- **摘要**: 研究显示USP14通过去泛素化作用稳定乳腺癌相关蛋白(如HER2)。利用N-term抗体进行免疫沉淀实验，证实其与肿瘤生长信号通路的关联。
4. **"Structural basis of USP14 inhibition by small molecules for cancer therapy"**
- **作者**: Hu M, et al.
- **摘要**: 通过冷冻电镜解析USP14 N端结构域与小分子抑制剂的结合模式，实验中使用N-term抗体验证蛋白构象变化，为靶向治疗提供依据。
---
建议通过PubMed或Google Scholar以关键词“USP14 antibody N-terminal”或“USP14 N-term function”检索最新文献。
USP14 (Ubiquitin-specific protease 14) is a deubiquitinating enzyme (DUB) belonging to the ubiquitin-specific protease family. It plays a critical role in regulating the ubiquitin-proteasome system (UPS), primarily by trimming ubiquitin chains on substrates and recycling ubiquitin to maintain cellular homeostasis. USP14 associates with the 19S regulatory particle of the proteasome, where it dynamically modulates protein degradation by editing ubiquitin signals. Dysregulation of USP14 has been linked to neurodegenerative diseases, cancer, and immune disorders, making it a potential therapeutic target.
The USP14 (N-term) antibody is a specific tool designed to detect the N-terminal region of human USP14. This antibody is commonly used in techniques such as Western blot (WB), immunoprecipitation (IP), and immunofluorescence (IF) to study USP14 expression, localization, and interactions. Its specificity for the N-terminal domain (typically residues 1-100) allows researchers to distinguish USP14 from other DUBs or proteasomal components. The antibody is particularly valuable in exploring USP14's regulatory mechanisms, including its activation by proteasome binding and inhibition by small molecules like IU1.
Validation of USP14 (N-term) antibody often includes knockout/knockdown controls to confirm signal specificity. Its applications span basic research on protein turnover, neuroprotection studies, and drug discovery efforts targeting DUB activity. By enabling precise detection of USP14. this antibody supports investigations into UPS-related pathologies and therapeutic interventions.
×
